We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VOYA:NYSEVoya Financial, Inc. Analysis

Data as of 2026-05-09 - not real-time

$81.59

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Voya Financial (VOYA) is trading at $81.59, comfortably above its 20‑day ($78.32), 50‑day ($72.04) and 200‑day ($73.44) simple moving averages, indicating a prevailing uptrend despite a neutral overall trend signal. The RSI of 65 suggests the stock is approaching overbought territory, while the MACD histogram has turned negative, hinting at short‑term momentum weakness near the $84 resistance level. The latest Q1 earnings beat expectations, with revenue up 8.2% YoY to $318 million and EPS improving to $2.26 from $2.15 a year ago, reinforcing the company’s earnings momentum.
Fundamentally, VOYA appears undervalued, posting a trailing P/E of 12.3 versus an industry average of 16.4 and a forward P/E of just 7.35, while its price‑to‑book (1.55) and price‑to‑sales (0.90) ratios are also below peer benchmarks. The dividend yield of 2.28% with a modest 27.8% payout ratio signals sustainability, and a forward EPS estimate of $11.10 signals strong earnings growth potential. However, the stock carries a higher‑than‑average beta (~1.1) and 30‑day volatility of ~28%, suggesting pronounced price swings, and its net‑debt position (debt $3.72 B vs cash $0.97 B) warrants monitoring.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price near resistance at $84
  • Negative MACD histogram indicating potential pullback
  • High RSI suggesting limited upside in the near term

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued multiples relative to industry
  • Strong earnings beat and accelerating EPS guidance
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend and stable cash flow generation
  • Long‑term growth prospects from retirement and benefits segments
  • Resilient market position within the financial conglomerate sector

Key Metrics & Analysis

Financial Health

Revenue Growth3.10%
Profit Margin8.24%
P/E Ratio12.3
ROE11.89%
ROA0.42%
Debt/Equity55.44
P/B Ratio1.5
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI65.3
Support$69.29
Resistance$84.00
MA 20$78.32
MA 50$72.04
MA 200$73.44
MACDBearish
VolumeStable
Fear & Greed Index90.73

Valuation

Target Price$86.64
Upside/Downside6.19%
GradeUndervalued
TypeBlend
Dividend Yield2.28%

Risk Assessment

Beta1.11
Volatility27.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.